Endometriosis Trial, Recruiting (NCT07560852)

Endometriosis Trial, Recruiting NCT07560852 Sponsor: ZIWIG Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT07560852 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a woman who has been given a prescription for Endotest by your doctor
You are between 18 and 43 years old
You have read, dated, and signed the consent form to take part in the study
You are part of the French healthcare system or have health insurance coverage from another country

Who may not be able to join:

You are currently pregnant
You have a past or current history of cancer or HIV infection
You currently have an active infection at the time your saliva sample would be collected
You have significant difficulty reading or understanding the language of the country where you would be taking part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 29 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +330630447709

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07560852

Sponsor: ZIWIG

Phase: Not Applicable

Status: Recruiting

Condition: Endometriosis

Trial contact: +330630447709

More information: https://clinicaltrials.gov/study/NCT07560852

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a woman who has been given a prescription for Endotest by your doctor
You are between 18 and 43 years old
You have read, dated, and signed the consent form to take part in the study
You are part of the French healthcare system or have health insurance coverage from another country

Who may not be able to join:

You are currently pregnant
You have a past or current history of cancer or HIV infection
You currently have an active infection at the time your saliva sample would be collected
You have significant difficulty reading or understanding the language of the country where you would be taking part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 29 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

ZIWIG

Registry

ClinicalTrials.gov

Start date

6 May 2026

Est. completion

31 July 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

To assess the impact of Endotest on quality of life and identify the factors associated with quality of life.; To assess the impact of Endotest on quality of life and identify the factors associated with quality of life.; To assess the impact of Endotest on quality of life and identify the factors associated with quality of life.; To assess the impact of Endotest on quality of life and identify the factors associated with quality of life.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov